RecruitingNCT07368582

Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )

Real World Pediatric Oncology Rehabilitation in Italy (ReWori) Study Protocol: Prognostic Factors of Functional Abilities in Children, Adolescents and Young Adults With Cancer Undergoing Rehabilitation


Sponsor

Associazione Italiana Ematologia Oncologia Pediatrica

Enrollment

249 participants

Start Date

Jul 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This observational study aims to describe changes in the functional abilities of children, adolescents and young adults with cancer who are undergoing physiotherapy or neuropsychomotor rehabilitation. This is real-world study aiming to describe normal rehabilitation pathways in many different hospitals or rehabilitation centres in Italy. The primary research question is: 1\) What are the longitudinal changes in functional abilities among these patients receiving physiotherapy or neuropsychomotor rehabilitation? The secondary research questions are: 1. What types of rehabilitation practices are implemented across AIEOP centres? 2. What are the rehabilitation needs among patients undergoing physiotherapy or neuropsychomotor rehabilitation? 3. How does health-related quality of life differ across the various stages of the rehabilitation pathway? Participants undergoing usual rehabilitation treatment are evaluated on their functional abilities on a monthly basis. If they agree to participate in this study, the main characteristics of the rehabilitation treatment and the monthly evaluation are collected.


Eligibility

Min Age: 0 MonthsMax Age: 24 Years

Inclusion Criteria4

  • Diagnosis of cancer,
  • Children, adolescents and young adults aged between 0 and 24 years old,
  • Children, adolescents and young adults at any stage of treatment and off therapy,
  • Children, adolescents and young adults referred to the Rehabilitation Service of AIEOP centres and Rehabilitation Centres that provide rehabilitation care for paediatric and young adult cancer patients involved in the study.

Exclusion Criteria1

  • Failure to sign the consent/assent form for participation in the study by the subject and/or by the person exercising parental authority.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRehabilitation intervention

This is an observational study, so it does not have a specific rehabilitation treatment protocol to be followed. The chort is followed with a periodic evaluation (monthly or every three month only for bone tumour diagnosis) during the period of the rehabilitation treatment


Locations(13)

Ospedale Papa Giovanni XXIII USS Oncoematologia Pediatrica

Bergamo, Italia, Italy

Istituto Ortopedico Rizzoli Bologna Servizio di Assistenza Infermieristica, Tecnica e della Riabilitazione (SAITER)"

Bologna, Italy

AS dell'Alto Adige comprensorio di Bolzano Dipartimento di Pediatria

Bolzano, Italy

IRCCS Eugenio Medea Associazione "La Nostra Famiglia"

Bosisio Parini, Italy

IRCCS Eugenio Medea Associazione "La Nostra Famiglia"

Brindisi, Italy

A.O.U. Policlinico Vittorio Emanuele U.O.C. Ematologia ed Oncologia Pediatrica con TMO

Catania, Italy

IRCCS Eugenio Medea Associazione "La Nostra Famiglia"

Conegliano, Italy

Azienda Ospedaliero-Universitaria "Anna Meyer" IRCCS - SOC Professioni tecnico sanitarie e della riabilitazione

Florence, Italy

Fondazione IRCCS Istituto Nazionale Tumori S.C. Pediatrica Oncologica Milano

Milan, Italy

Azienda Ospedale Università di Modena Dipartimento Materno Infantile, Unità Operativa complessa di Pediatria ad indirizzo oncoematologico

Modena, Italy

IRCCS Ospedale Pediatrico "Bambino Gesù" Dipartimento Ematologia Oncologia e medicina trasfusionale

Roma, Italy

AOU Città della Salute e della Scienza di Torino

Torino, Italy

IRCCS Materno Infantile "Burlo Garofolo" Dipartimento Pediatrico S.C. Onco-ematologia Pediatrica SS Trapianto di Midollo

Trieste, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07368582


Related Trials